Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

GLMD

Galmed Pharmaceuticals Ltd.

CIK 0001595353 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$4.30
↓ 0.25 (-5.59%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Technicals; Risks: Fundamentals; Excluded: Ownership, Options (no data)

Key stats

Market Cap
$35.57M
P/E Ratio
-3.45
EPS
2.39
Dividend Yield
Not covered
52W Position
77%
Beta
-4.84

Valuation multiples

Fwd P/E
Not covered
PEG
0.00
P/B
2.25
P/S
Not covered
EV/Revenue
Not covered
ROE
-65.3%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 77%
$0.41$5.45

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$10.31M
Total Assets
$18.63M
Free Cash Flow
–

Recent news